A detailed history of Traveka Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Traveka Wealth, LLC holds 8,552 shares of NVO stock, worth $898,473. This represents 0.52% of its overall portfolio holdings.

Number of Shares
8,552
Previous 8,635 0.96%
Holding current value
$898,473
Previous $1.23 Billion 17.38%
% of portfolio
0.52%
Previous 0.6%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$119.07 - $145.42 $9,882 - $12,069
-83 Reduced 0.96%
8,552 $1.02 Billion
Q2 2024

Jul 16, 2024

BUY
$122.71 - $146.91 $89,823 - $107,538
732 Added 9.26%
8,635 $1.23 Billion
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $54,730 - $72,853
536 Added 7.28%
7,903 $1.01 Billion
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $646,675 - $776,850
7,367 New
7,367 $762 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Traveka Wealth, LLC Portfolio

Follow Traveka Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traveka Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traveka Wealth, LLC with notifications on news.